Sponsor pipeline

REGEnLIFE SAS clinical trial pipeline

Get alerts when REGEnLIFE SAS's trials change

1 active trials 1 recruiting 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-08-11
Primary completion pushed: 2026-06 → 2027-06
Completion pushed: 2026-12 → 2027-12
NCT05926011 Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

Active trials by phase

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Not applicable
NCT05926011 Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease Alzheimer Disease Recruiting 2026-08-21

Disease areas by active trials

Alzheimer's Disease (1)

Get alerts when REGEnLIFE SAS's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free